In a letter to the president, he wrote, "I urge the administration to consider what steps can be taken under existing authority to prepare and even begin to use a pathway for generic biologics."
Read the full story here.
If you'r
e interested in networking with other professionals in the field of Biosimilars, join our LinkedIn Group here.|
Share this article with your social network, just click below to share now!
|
|
|








No comments :
Post a Comment